Growth hormone deficiency (GHD) is a rare but serious condition that affects how children grow and develop. Caused by the body’s inability to produce enough growth hormone, it can lead to short stature, delayed puberty, and long-term metabolic complications. Growth hormone plays a key role in bone development, muscle strength, and glucose balance. Without treatment, children with GHD may face both physical and emotional challenges as they grow. The best chance for effective treatment comes early—while the growth plates are still open during childhood and adolescence.
One of the best-known stories of a person with GHD is that of soccer legend Lionel Messi. Diagnosed at age 11, he faced an uncertain future. Without consistent treatment, his physical development—and the stellar athletic career that followed—might never have been possible. His story illustrates what timely intervention can achieve.
Who Needs Growth Hormone Support
Growth hormone therapy is prescribed not only for children with isolated GHD but also for those with growth delays caused by genetic or other developmental conditions. Diagnosis typically begins when a child’s height falls significantly below the average for their age. Such children are typically tested to measure their levels of IGF-1 and IGFBP-3, two key markers that reflect how well the body responds to growth hormone. Doctors may also look for signs such as delayed puberty or low blood sugar. A stimulation test is often used to confirm the diagnosis. Children with conditions like Turner syndrome, Prader-Willi syndrome, Noonan syndrome, and those born small for their gestational age may all benefit from growth hormone therapy. For all of them, access to timely, consistent treatment can shape lifelong outcomes.
The Burden of Daily Injections
For most individuals requiring growth hormone therapy, treatment comes with a difficult reality: years of daily injections. Although this routine is medically necessary, it can be painful and emotionally draining. Children often respond to injections with fear or resistance, while parents must manage the stress of daily administration. Over time, these challenges can lead to missed doses or treatment dropout—compromising long-term results. Even with the development of long-acting injectables, the core issue remains. The needle is still there.
Delivering Without Needles
At Sinedore, we are redefining how growth hormone is delivered. Our EndoEase™ platform turns injectable biologics into sublingual tablets, offering a painless, non-invasive alternative to daily shots. Designed for ease of use and gentle administration, EndoEase™ eliminates the fear and discomfort associated with needles while maintaining therapeutic effectiveness. This patient-friendly approach helps families stay on track with treatment, day after day. Growth hormone therapy should help children thrive, not cause them distress. EndoEase™ offers a way forward—one that alleviates stress from families and empowers children. By removing the barrier of injection pain, we are making growth treatment more accessible and more humane. At Sinedore, we believe that growth challenges should be overcome with sensitivity, not fear. Because every child deserves to reach their full height—and their full potential.
